The monoclonal antibody custom service market is growing mainly due to rising investment research and development. According to a recent study report published by the Market Research Future, the monoclonal antibody custom service market is booming and expected to gain prominence over the forecast period. The Global Monoclonal Antibody Custom Service Market Share is expected to register a CAGR of 10.84% and is projected to reach USD 1,461.93 Million During The Forecast Period.
Monoclonal is a class of antibodies, which are derived from the identical offspring of a hybridomas. These antibodies can be grown indefinitely and are very specific for a particular location in the body derived from a single clone. Monoclonal antibodies recognize and bind to antigens to discriminate between specific epitopes, which provides protection against disease organisms. The specificity of MABs allow its binding to cancerous cells, which then seek outs to destroy the cancer cells. Monoclonal antibody custom service offers the selection of the developed rat and mouse hybridomas for the production of custom monoclonal antibodies from synthesized peptide or recombinant protein antigens. These services provides a comprehensive services for antibody cloning, expression, engineering, and purification in addition to custom antibody development for multiple pharmaceutical and biotechnological companies. The prices of custom antibody service depends on various factors such as type, titer and functional specifications of antibody produced. The pricing for custom monoclonal antibodies ranges from USD 3,500 to USD 11,500 per order.
Notably, increasing investment in RD is the primary driver for monoclonal antibody custom service market. As per the National Science Foundation, in 2015, US RD funding was USD 499 billion. In last few years, the Chinese RD investment is growing at a rate of 10% per year. Asia accounts for more than 42% of total RD investments and the share is continuously increasing each year. market report offers comprehensive study of the Monoclonal Antibody Treatment ,Overview, Regional Overview, Segments.
Other push factors such as, increasing prevalence of chronic diseases and infection, increasing prevalence of immunological diseases, and rising healthcare expenditure are also fuelling the growth of the market. According to the UNAIDS, at the end of 2015, approximately 36.7 million people worldwide were suffering from HIV/AIDS and among them 1.8 million were children below 15 years of age.
Despite these drivers, lack of awareness about the possible applications of monoclonal antibody, and high cost of the monoclonal antibody services regulatory are expected to hinder the growth of the market. Monoclonal antibody production is divided into different phases, with a non-refundable cost of around USD 1,000 to cover the material cost to initiate the project.
Monoclonal Antibody Custom Service Market - Competitive Analysis
Thermo Fisher Scientific, GenScript, Abnova Corporation, Creative-Biolabs, Abcam plc, ProMab Biotechnologies Inc, Envigo are some of the prominent players at the forefront of competition in the monoclonal antibody custom service market and are profiled in MRFR Analysis.
Due to rising research and development expenditure various existing and new marketers are continuously coming up with advanced products to control various chronic diseases. The global monoclonal antibody custom service market is currently dominated by few players.
Thermo Fisher Scientific is one of them by holding a strong share in the market. The company is involved in serving the science with improve patient diagnostics, life sciences research, solve complex analytical challenges, and increase laboratory productivity. In August, 2017, Institute of Pathology Heidelberg collaborate with Thermo Fisher Scientific Center of Excellence Program to Drive Oncology Companion Diagnostic Development in Europe, and in the same year, the company has got first FDA-Approval of Cell Therapy for Leukemia which utilizes Thermo Fisher Scientific's CTS Dynabeads Technology.
GenScript is another renowned market player in monoclonal antibody custom service market. The product portfolio of company includes MonoExpress Fast mAb Services, Semi-custom Monoclonal Antibody Production, Fully-custom mAb Generation Services, MonoRab Rabbit mAb Services, Hybridoma Generation for Therapeutic Antibody Discovery, MamPower Guaranteed Antibody Package, and others Therapeutic Antibody Discovery Services. In June, 2017, the company launched custom rabbit monoclonal antibody service, and in the same year, GenScript partnered with iGEM to expand synthetic biology community in China.
Creative-Biolabs produces and supplies biotech products and services for early drug discovery and development, including various phage display libraries such as pre-made libraries, phage display services, antibody sequencing, and antibody humanization. The company offers broad range of custom monoclonal antibody development services such as Monoclonal Antibody Caninization Service, Monoclonal Antibody Murinization Service, Monoclonal Human Antibody Production, Monoclonal Mouse Antibody Production, Monoclonal Human Antibody Production, Monoclonal Monkey (NHP) Antibody Production, Monoclonal Rat Antibody Production, and others.
Key Players
Some of key the players in the market are Thermo Fisher Scientific, GenScript, Abnova Corporation, Creative-Biolabs, Abcam plc, ProMab Biotechnologies Inc, Envigo, and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
Email: [email protected]
